Role of Aahar and Panchakarma on restoration of euglycemia in known type II diabetes mellitus

Vaidehi Revandkar; Bipin Gond; Rahul Mandole; Gurudatta Amin; Pravin Ghadigaonkar

doi:10.18203/2320-6012.ijrms20233378

Authors

Vaidehi Revandkar Department of Ayurved Medicine, Borivali East Madhavbaug Cardiac Clinic, Maharashtra, India
Bipin Gond Department of Ayurved Medicine, ZMH of Western Mumbai, Marathwada, Madhya Pradesh and Delhi NCR Zone, India
Rahul Mandole Department of Ayurved Medicine, Borivali East Madhavbaug Cardiac Clinic, Maharashtra, India
Gurudatta Amin Department of Ayurved Medicine, Borivali East Madhavbaug Cardiac Clinic, Maharashtra, India
Pravin Ghadigaonkar Department of Ayurved Medicine, Borivali East Madhavbaug Cardiac Clinic, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20233378

Keywords:

Ayurveda, Glycosylated hemoglobin, Panchakarma, Body mass index, Diabetes mellitus

Abstract

Background: Diabetes mellitus, in particular, has emerged as a significant health concern, affecting millions of individuals and placing a considerable strain on the healthcare system. Promoting remission of diabetes, wherein patients achieve a state of sustained blood sugar control without the need for ongoing medication or with a reduced reliance on medication, can yield remarkable benefits. This study sought to understand the role of Aahar and Panchakarma on restoration of euglycemia in known type 2 diabetes patients.

Methods: A retrospective, observational, cohort study was conducted at Madhavbaug Cardiac Care Clinic between April 2021 and April 2022 in Maharashtra, India. Patients aged 18 years and older with a diagnosis of type 2 diabetes mellitus with glycated haemoglobin level (HbA1c) >7% and had participated in the Comprehensive Diabetes Care (CDC) program were included in this study. Parameters such as HbA1c, body weight, body mass index (BMI), and dependence on conventional allopathic medication were assessed at the end of the CDC program. Follow-up was conducted at 90 days. Day 1 and day 90 data were compared.

Results: Of the 45 patients, 17 (40.5%) patients had a negative glucose tolerance and 14 (33.3%) patients had impaired glucose tolerance. HbA1c, body weight, and BMI improved at the end of CDC program. Dependency on conventional allopathic medications was also reduced.

Conclusions: Restoration of euglycemia in patients with type 2 diabetes mellitus is possible, however, further studies to understand the affecting factors are warranted.

Metrics

Metrics Loading ...

References

Chattopadhyay K, Kapoor N, Heinrich M, Mitra A, Mittal M, Lewis SA, et al. Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners. Front Med (Lausanne). 2023;10:1043715.

Banerjee S, Debnath P, Rao PN, Tripathy TB, Adhikari A, Debnath PK. Ayurveda in changing scenario of diabetes management for developing safe and effective treatment choices for the future. J Complement Integr Med. 2015;12(2):101-10.

Corathers SD, Peavie S, Salehi M. Complications of diabetes therapy. Endocrinol Metab Clin North Am. 2013;42(4):947-70.

Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95-104.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(Suppl 1):S62-7.

Sane R, Sabir IA, Naik MS, Shingan T, Mandole R. To study efficacy of Comprehensive Diabetes Care (CDC) management program in type II diabetic obese patients: An observational study. Int J Ayurveda Pharma Res. 2018;6(6):6-12.

Sane R, Naik M, Khair K, Mahajan H, Pawar D, Revandkar V, et al. Effect of comprehensive diabetes care on glycaemic control with reduction in dependency of oral hypoglycaemic medicines in pre-obese diabetic patients: A retrospective study. Int J Curr Res Acad Rev. 2018;6(11):73-81.

Sane R, Ghadigaonkar P, Chaure R, Jain S, Wahane S, Nadapude A, et al. Efficacy of Comprehensive Diabetes Care (CDC) management program in elderly male patients of type II diabetes mellitus: A retrospective study. Int J Diabetes Endocrinol. 2018;3(2):29.

Shingan TN, Kamlapure S, Kulthe N. Role of ayurveda based comprehensive diabetic care program in restoration of euglycemia in known type 2 diabetic mellitus. Int J Diabet Endocrinol. 2022;7(3):91-5.

Sane R, Naik M, Khair K, Harsha H, Pawar D, Revandkar V, Mandole R. Effect of Comprehensive Diabetes Care on Glycaemic control with reduction in dependency of oral hypoglycaemic medicines in pre-obese diabetic patients: A retrospective study. Int J Curr Res Acad Rev. 2018;6(11):73-81.

Sane R, Mandole R, Amin GA, Ghadigaonkar P, Paranjape S. Effectiveness of Comprehensive Diabetes Care (CDC) on diabetic patients: An observational study. Int J Innovat Res Med Sci. 2020;5(8):314-9.

Sane R, Mandole R, Amin GA, Ghadigaokar P, Paranjape S, Gond B, et al. Role of comprehensive diabetes care in known diabetes patients from western Mumbai region: an observational study. Int J Res Med Sci. 2023;8(8):3013-8.